« Return to News | Awards & Advancement

Parexel Names New CIO

Friday, January 16, 2009 09:04 AM

Josephine Hoppe has joined contract research organization (CRO) Parexel as corporate vice president and chief information officer (CIO). Hoppe will handle Parexel’s IT initiatives and manage the integration of technology solutions with global business processes. Prior to joining Parexel, Hoppe was the CIO of Pegasystems, a business process management company.

In other personnel news from the clinical trial industry:

The Association of Clinical Research Professionals (ACRP) and the Association of Clinical Research Organizations (ACRO) both appointed new chairs for 2009.

ACRP elected David Vulcano chair of the Association Board of Trustees, replacing 2008 chair Deborah Lasher. Vulcano is assistant vice president for clinical research with Hospital Corporation of America in Nashville, Tenn.

Derek Winstanly, executive vice president of strategic business partnerships at Quintiles, is ACRO’s newly named chair for 2009. William Sharbaugh, chief operating officer at PPD, is chair-elect. 

Imaging CRO WorldCare Clinical (WCC) has appointed Richard Walovitch as chief medical officer. Walovitch was senior vice president of clinical research at Acusphere before joining WCC.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.